Great write up mate! Heartbeam is definitely an under the radar opportunity with little coverage. Once they receive FDA approvals, the company could really fly
Thanks. Good to follow this stock even if you don't invest in it right now. It's so under radar that the share price could totally under react to the second FDA approval which would be a really good de-risked entry opportunity
Great write up mate! Heartbeam is definitely an under the radar opportunity with little coverage. Once they receive FDA approvals, the company could really fly
Thanks. Good to follow this stock even if you don't invest in it right now. It's so under radar that the share price could totally under react to the second FDA approval which would be a really good de-risked entry opportunity